Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Histone Deacetylase Inhibitor, PCI-24781, Induces Growth Inhibition and Apoptosis in Hematopoietic Tumor-Derived Cell Lines and Primary Leukemia Cells.

Joseph Buggy, PhD, Sriram Balasubramanian, PhD, Jason Ramos, PhD, Mint Sirisawad, MS, Louie Naumovski, MD, PhD

Blood (2006) 108 (11): 4399.

https://doi.org/10.1182/blood.V108.11.4399.4399

Published: 2006

Journal Articles

ASPP2 Haploinsufficiency Promotes Tumor Formation in a Mouse Model.

Kerstin M. Kampa, MD, Jared D. Acoba, M.D., Dexi Chen, M.D.,Ph.D., Kelly Beemer, M.S., Joel Gay, Zhiyi Zhu, M.S., Emerson Padiernos, B.S., Alice Fan, M.D., Dean Felsher, M.D.,Ph.D., Christopher Corless, M.D.,Ph.D., Louie Naumovski, M.D.,Ph.D., Charles D. Lopez, M.D.,Ph.D.

Blood (2006) 108 (11): 4333.

https://doi.org/10.1182/blood.V108.11.4333.4333

Published: 2006

Journal Articles

Motexafin Gadolinium and Other Metallotexaphyrins Upregulate Heme Oxygenase-1.

Mint Sirisawad, Jun Chen, Jason Ramos, Richard A. Miller, Louie Naumovski

Blood (2005) 106 (11): 4468.

https://doi.org/10.1182/blood.V106.11.4468.4468

Published: 2005

Journal Articles

Motexafin Gadolinium Upregulates pAkt Levels and Synergizes with Inhibitors of Akt Phosphorylation.

Jason Ramos, PhD, Mint Sirisawad, BS, Richard A. Miller, Louie Naumovski, MD-PhD

Blood (2005) 106 (11): 4275.

https://doi.org/10.1182/blood.V106.11.4275.4275

Published: 2005

Journal Articles

Growth Inhibition or Apoptosis after Treatment with Motexafin Gadolinium and Celecoxib Is Cell Line Dependent and Correlates with p27 Levels.

Jason Ramos, PhD, Mint Sirisawad, BS, Jun Chen, PhD, Richard A. Miller, MD, Louie Naumovski, MD-PhD

Blood (2005) 106 (11): 4296.

https://doi.org/10.1182/blood.V106.11.4296.4296

Published: 2005

Journal Articles

Motexafin Gadolinium Causes Apoptosis in Lymphoma Cells by Increasing Intracellular Free Zinc and Disrupting Redox Balance.

Darren Magda, PhD, Philip Lecane, PhD, Mazen W. Karaman, PhD, Mint Sirisawad, PhD, Louie Naumovski, MD, PhD, Richard A. Miller, MD, Joseph G. Hacia, PhD

Blood (2005) 106 (11): 4827.

https://doi.org/10.1182/blood.V106.11.4827.4827

Published: 2005

Journal Articles

Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines: Role of Elevated Intracellular Calcium.

Jun Chen, PhD, Jason Ramos, PhD, Mint Sirisawad, BS, Richard A. Miller, MD, Louie Naumovski, MD-PhD

Blood (2005) 106 (11): 4829.

https://doi.org/10.1182/blood.V106.11.4829.4829

Published: 2005

Journal Articles

Effects of the Redox Mediator Motexafin Gadolinium in a Pilot Phase I Trial in Refractory Chronic Lymphocytic Leukemia (CLL).

Thomas S. Lin, MD, PhD, Sabyasachi Biswas, PhD, Louie Naumovski, MD, PhD, Phillip Lecane, PhD, Margaret S. Lucas, PA-C, Mollie E. Moran, CRNP, Andrew P. Mone, MD, PhD, David M. Lucas, PhD, See-Chun Phan, MD, Richard A. Miller, MD, John C. Byrd, MD

Blood (2004) 104 (11): 3486.

https://doi.org/10.1182/blood.V104.11.3486.3486

Published: 2004

Journal Articles

Motexafin Gadolinium Induces Apoptosis in Lymphoid Cell Lines and Demonstrates Enhanced Biological Activity with Akt Kinase Inhibitors.

Louie Naumovski, MD-PhD, Jason Ramos, PhD, Jun Chen, PhD, Mint Sirisawad, BA, David Lucas, PhD, John C. Byrd, MD, Richard A. Miller, MD

Blood (2004) 104 (11): 3406.

https://doi.org/10.1182/blood.V104.11.3406.3406

Published: 2004

Journal Articles

Sapphyrins Exhibit Tumor Selectivity and Efficacy in Animal Models of Hematologic Malignancies.

Louie Naumovski, MD-PhD, Mint Sirisawad, BA, Philip Lecane, PhD, Jason Ramos, PhD, Darren Magda, PhD, Zhong Wang, PhD, Patti Thiemann, BS, Garry Boswell, PharmD, Dong-Gyu Cho, BS, Jonathan Sessler, PhD, Richard A. Miller, MD

Blood (2004) 104 (11): 2501.

https://doi.org/10.1182/blood.V104.11.2501.2501

Published: 2004

Journal Articles

Motexafin Gadolinium, a Redox Mediator, Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells and Is Additive or Synergistic with Fludarabine.

Louie Naumovski, MD-PhD, Nancy D. Bone, BA, Mint Sirisawad, BA, Richard Miller, MD, Diane F. Jelinek, PhD, Renee C. Tschumper, BA, Neil E. Kay, MD

Blood (2004) 104 (11): 4799.

https://doi.org/10.1182/blood.V104.11.4799.4799

Published: 2004

Journal Articles

Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines.

Jun Chen, PhD, Jason Ramos, PhD, Mint Sirisawad, BA, Richard A. Miller, MD, Louie Naumovski, MD-PhD

Blood (2004) 104 (11): 2296.

https://doi.org/10.1182/blood.V104.11.2296.2296

Published: 2004

Journal Articles

Quantitative Analysis of Apoptotic Cell Death Using Proton Nuclear Magnetic Resonance Spectroscopy

Francis G. Blankenberg, Peter D. Katsikis, Richard W. Storrs, Christian Beaulieu, Daniel Spielman, James Y. Chen, Louie Naumovski, Jonathan F. Tait

Blood (1997) 89 (10): 3778–3786.

https://doi.org/10.1182/blood.V89.10.3778

Published: 1997

NARROW

Histone Deacetylase Inhibitor, PCI-24781, Induces Growth Inhibition and Apoptosis in Hematopoietic Tumor-Derived Cell Lines and Primary Leukemia Cells.

ASPP2 Haploinsufficiency Promotes Tumor Formation in a Mouse Model.

Motexafin Gadolinium and Other Metallotexaphyrins Upregulate Heme Oxygenase-1.

Motexafin Gadolinium Upregulates pAkt Levels and Synergizes with Inhibitors of Akt Phosphorylation.

Growth Inhibition or Apoptosis after Treatment with Motexafin Gadolinium and Celecoxib Is Cell Line Dependent and Correlates with p27 Levels.

Motexafin Gadolinium Causes Apoptosis in Lymphoma Cells by Increasing Intracellular Free Zinc and Disrupting Redox Balance.

Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines: Role of Elevated Intracellular Calcium.

Effects of the Redox Mediator Motexafin Gadolinium in a Pilot Phase I Trial in Refractory Chronic Lymphocytic Leukemia (CLL).

Motexafin Gadolinium Induces Apoptosis in Lymphoid Cell Lines and Demonstrates Enhanced Biological Activity with Akt Kinase Inhibitors.

Sapphyrins Exhibit Tumor Selectivity and Efficacy in Animal Models of Hematologic Malignancies.

Motexafin Gadolinium, a Redox Mediator, Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells and Is Additive or Synergistic with Fludarabine.

Motexafin Gadolinium Enhances Rituximab-Induced Cytotoxicity Against B-Cell Lymphoma Cell Lines.

Quantitative Analysis of Apoptotic Cell Death Using Proton Nuclear Magnetic Resonance Spectroscopy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only